tiprankstipranks
Immunoprecise Antibodies Ltd. (IPA)
:IPA
US Market

ImmunoPrecise Antibodies (IPA) Income Statement

Compare
255 Followers

ImmunoPrecise Antibodies Income Statement

Last quarter (Q2 2025), ImmunoPrecise Antibodies's total revenue was C$6.13M, a decrease of -0.41% from the same quarter last year. In Q2, ImmunoPrecise Antibodies's net income was C$-2.55M. See ImmunoPrecise Antibodies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
C$ 24.52MC$ 20.66MC$ 19.36MC$ 17.91MC$ 14.06M
Gross Profit
C$ 12.05MC$ 11.56MC$ 10.98MC$ 11.54MC$ 8.03M
Operating Expenses
C$ 12.05MC$ 39.78MC$ 27.15MC$ 15.71MC$ 12.08M
Depreciation and Amortization
C$ 5.74MC$ 6.68MC$ 3.77MC$ 3.71MC$ 3.41M
EBITDA
C$ -22.95MC$ -21.04MC$ -11.99MC$ -1.42MC$ -449.00K
Operating Income
C$ -13.76MC$ -26.09MC$ -15.78MC$ -6.65MC$ -4.09M
Other Income/Expenses
C$ -14.94MC$ -2.14MC$ -67.00KC$ -2.08MC$ -1.47M
Pretax Income
C$ -28.70MC$ -27.75MC$ -15.85MC$ -6.00MC$ -5.29M
Net Income
C$ -27.18MC$ -26.56MC$ -16.71MC$ -7.34MC$ -4.95M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -1.06C$ -1.07C$ -0.85C$ -0.45C$ -0.36
Diluted EPS
C$ -1.06C$ -1.07C$ -0.85C$ -0.45C$ -0.36
Weighted Average Shares Outstanding
25.64M 24.90M 19.69M 16.47M 13.63M
Weighted Average Shares Outstanding (Diluted)
25.64M 24.90M 19.69M 16.47M 13.63M
Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis